These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16636232)

  • 1. Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?
    Qureshi AI; Ezzeddine MA; Nasar A; Suri MF; Kirmani JF; Janjua N; Divani AA
    Neurology; 2006 Apr; 66(8):1171-4. PubMed ID: 16636232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?
    Agarwal P; Kumar S; Hariharan S; Eshkar N; Verro P; Cohen B; Sen S
    Cerebrovasc Dis; 2004; 17(2-3):182-90. PubMed ID: 14707420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action.
    Bhatia R; Hill MD; Shobha N; Menon B; Bal S; Kochar P; Watson T; Goyal M; Demchuk AM
    Stroke; 2010 Oct; 41(10):2254-8. PubMed ID: 20829513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II.
    Dzialowski I; Hill MD; Coutts SB; Demchuk AM; Kent DM; Wunderlich O; von Kummer R
    Stroke; 2006 Apr; 37(4):973-8. PubMed ID: 16497977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
    Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK
    Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography.
    Nichols C; Khoury J; Brott T; Broderick J
    J Stroke Cerebrovasc Dis; 2008; 17(2):64-8. PubMed ID: 18346647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.
    Patel SC; Levine SR; Tilley BC; Grotta JC; Lu M; Frankel M; Haley EC; Brott TG; Broderick JP; Horowitz S; Lyden PD; Lewandowski CA; Marler JR; Welch KM;
    JAMA; 2001 Dec; 286(22):2830-8. PubMed ID: 11735758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eligibility determination for intravenous thrombolysis based on radiology interpretation report of the head CT scan in patients with acute ischemic stroke.
    Hassan AE; Majidi S; Janjua NA; Chaudhry SA; Tekle WG; Grigoryan M; Qureshi AI
    J Neuroimaging; 2014; 24(4):349-53. PubMed ID: 24015702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperdense middle cerebral artery sign and outcome after intravenous thrombolysis for acute ischemic stroke.
    Aries MJ; Uyttenboogaart M; Koopman K; Rödiger LA; Vroomen PC; De Keyser J; Luijckx GJ
    J Neurol Sci; 2009 Oct; 285(1-2):114-7. PubMed ID: 19576595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very mild stroke patients benefit from intravenous tissue plasminogen activator without increase of intracranial hemorrhage.
    Hassan AE; Hassanzadeh B; Tohidi V; Kirmani JF
    South Med J; 2010 May; 103(5):398-402. PubMed ID: 20375952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
    Stroke; 2000 Dec; 31(12):2912-9. PubMed ID: 11108748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
    Shaltoni HM; Albright KC; Gonzales NR; Weir RU; Khaja AM; Sugg RM; Campbell MS; Cacayorin ED; Grotta JC; Noser EA
    Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prerequisites, indications and contraindications of IV-lysis of ischemic stroke with rt-PA].
    Marx P; Hartmann A; Leistner S; Nohr R; Koennecke HC
    Fortschr Neurol Psychiatr; 2001 Aug; 69(8):346-52. PubMed ID: 11584683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign.
    Mattle HP; Arnold M; Georgiadis D; Baumann C; Nedeltchev K; Benninger D; Remonda L; von Büdingen C; Diana A; Pangalu A; Schroth G; Baumgartner RW
    Stroke; 2008 Feb; 39(2):379-83. PubMed ID: 18096842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute stroke with hyperdense middle cerebral artery sign benefits from IV rtPA.
    Tartaglia MC; Di Legge S; Saposnik G; Jain V; Chan R; Bussière M; Hachinski V; Frank C; Hesser K; Pelz D
    Can J Neurol Sci; 2008 Nov; 35(5):583-7. PubMed ID: 19235441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients.
    Lee KY; Han SW; Kim SH; Nam HS; Ahn SW; Kim DJ; Seo SH; Kim DI; Heo JH
    Stroke; 2007 Jan; 38(1):192-3. PubMed ID: 17110611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
    Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
    Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.